Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 369 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Polyzos, Stergios A [Clear All Filters]
Impact of Active Helicobacter pylori Infection-related Metabolic Syndrome on Systemic Arterial Hypertension..
Arq Bras Cardiol. 119(3), 502-504.
(2022). Letter to the Editor Regarding "The Association of Helicobacter pylori, Eradication, and Early Complications of Laparoscopic Sleeve Gastrectomy" by Abeid et al..
Obes Surg. 32(6), 2079-2080.
(2022). Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver disease..
Hormones (Athens).
(2022). Metabolism, Clinical and Experimental: seventy years young and growing..
Metabolism. 155333.
(2022). Metreleptin for the treatment of lipodystrophy: leading the way among novel therapeutics for this unmet clinical need..
Curr Med Res Opin. 38(6), 885-888.
(2022). Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications..
Diabetes Obes Metab. 24(9), 1702-1720.
(2022). Potential impact of Helicobacter pylori and metabolic syndrome-related non-alcoholic fatty liver disease on cardio-cerebrovascular disease..
Metabolism. 135, 155276.
(2022). Potential Impact of Helicobacter pylori Infection on Pancreatic Cancer Pathophysiology..
J Gastrointest Cancer.
(2022). A potential impact of Helicobacter pylori-related metabolic syndrome on early and long-term outcomes of bariatric surgery..
Gastrointest Endosc. 96(6), 1088-1089.
(2022). Potential impact of Helicobacter pylori-related metabolic syndrome on arterial hypertension outcomes..
Am J Hypertens.
(2022).
(2022).
(2022). Addressing the epidemic of fatty liver disease: A call to action, a call to collaboration, a call to moving the field forward..
Metabolism. 122, 154781.
(2021). Adult hypophosphatasia treated with reduced frequency of teriparatide dosing..
J Musculoskelet Neuronal Interact. 21(4), 584-589.
(2021). Cilofexor for the Treatment of Nonalcoholic Steatohepatitis.
Curr Vasc Pharmacol.
(2021).
(2021). Circulating tumor necrosis factor-α levels in non-alcoholic fatty liver disease: A systematic review and a meta-analysis..
J Gastroenterol Hepatol.
(2021). Comparative Effect of Zoledronate at 6 Versus 18 Months Following Denosumab Discontinuation..
Calcif Tissue Int.
(2021). Diabetes mellitus: 100 years since the discovery of insulin..
Metabolism. 118, 154737.
(2021). The duration of denosumab treatment and the efficacy of zoledronate to preserve bone mineral density after its discontinuation..
J Clin Endocrinol Metab.
(2021). Effect of spironolactone on pharmacological treatment of nonalcoholic fatty liver disease..
Minerva Endocrinol (Torino).
(2021). Efficacy of Antiosteoporotic Medications in Patients With Rebound-Associated Fractures After Denosumab Discontinuation..
J Clin Densitom.
(2021). Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease..
Arch Med Res. 52(1), 25-37.
(2021). Helicobacter pylori infection and diabetes mellitus..
Diabetes Metab Syndr. 15(3), 845-846.
(2021).
(2021).